Clinical Trial Update: The FEIBA NovoSeven Comparative Study [NA]

View source ↗

Summary

A completed clinical trial comparing FEIBA versus NovoSeven in patients with severe Hemophilia A with inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FEIBA (activated prothrombin complex concentrate)
• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Skane University Hospital | Conditions: Severe Hemophilia A With an Inhibitor | NA | Status: COMPLETED